We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Omega Diagnostics Group Plc | LSE:ODX | London | Ordinary Share | GB00B1VCP282 | ORD 4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 2.20 | 2.00 | 2.40 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
02/3/2021 07:23 | Note that Screen4 are on the Goverment approved provider list "offering International Travelers access to the Test to Release Covid19 Services. We have partnered with Oncologica Ltd, a government approved laboratory to provide a reliable and smooth process for your testing needs": "If you are returning to England from a country not on the government’s travel corridor list, you will need to self-isolate and not leave your home for 10 days – unless you take a Covid19 and receive a negative result. This is known as Test to Release. The earliest you can take the test is 5 full days after you left a country not on the travel corridor list. You will still need to self-isolate until you receive a negative result. etc" | rivaldo | |
02/3/2021 07:17 | Thanks Rivaldo. Probably caused the small flurry of activity late yesterday as those with a little heads up for an RNS bought in - IMO | coley15 | |
02/3/2021 07:07 | News..... "Contract with Screen4 for COVID-19 antibody laboratory-based testing service Omega (AIM: ODX), the medical diagnostics company focused on CD4, infectious diseases and food intolerance, announces that it has signed a contract with Screen4 Ltd ("Screen4") to provide a testing service using the Mologic ELISA(1) antibody test for COVID-19 from the Company's in-house testing laboratory in Littleport, Cambridgeshire . This follows the launch of the COVID-19 antibody testing service, as announced on 26 January 2021. The contract is for an initial term of three years. Screen4 is a leading provider of COVID-19 testing services and diagnostic testing services to the aviation, petrochemical, occupational health and consumer markets in the UK and across the Middle east and Far East regions. Screen4 is an Approved Provider under the UK Government General testing and 'Test to Release' Scheme in the UK. Colin King, CEO of Omega, commented: "Following on from setting up and launching our in-house testing service that utilises the Mologic COVID-19 IgG ELISA, I am pleased to be working with Screen4 as our first customer. Screen4 provide a synergistic approach involving health assessment and patient support to their clients." David Grouse, Managing Director of Screen4, commented: "We are delighted to be involved with Omega Diagnostics on this project. Omega are at the forefront in the development of vital testing technologies to help fight the Covid-19 virus. We will be supporting them through the distribution of their latest product - the COVID-19 ELISA Antibody testing service. The simple, usable nature of this product, particularly with regards to a properly CE marked self-collection sample kit for Home Use, is a major step forward in helping people understand their current status with regards to the virus." (1) ELISA (Enzyme Linked Immuno-Sorbent Assay) tests are one of the most tested and proven laboratory technologies used by the global diagnostic industry and remain the principal reference point from which rapid diagnostics are coordinated, especially serological tests, including tests for COVID-19." | rivaldo | |
02/3/2021 07:05 | Today's rns, was that reason for late surge in vol and price yesterday afternoon? | ayl30 | |
01/3/2021 21:35 | Thats why Prince philips in hospital. ;-/ | jayrh | |
01/3/2021 21:03 | Queen says Covid vaccine 'didn't hurt at all' The Queen has urged people to get a Covid vaccine when they are offered one, saying hers "didn't hurt at all". The monarch, 94, and the Duke of Edinburgh, 99, received their first doses of the vaccine in January. In a video call with health leaders delivering the Covid vaccine across the UK, the Queen was asked about her experience of having the jab. She smiled as she replied: "Well, as far as I can make out it was quite harmless. "It was very quick, and I've had lots of letters from people who've been very surprised by how easy it was to get the vaccine." "It didn't hurt at all," the Queen said, adding that she has since felt "protected" | donald t | |
01/3/2021 20:27 | Rise into close usually implies mms will bring it down in the morning. RNS would change that. | letmepass | |
01/3/2021 20:23 | Lots of lovely tweets again so we will get something. | moneymachine2 | |
01/3/2021 19:07 | moneymachine2, Looking at the rise into closed, you never know!! | barrywhit | |
01/3/2021 18:27 | See,I did say it. | moneymachine2 | |
01/3/2021 17:31 | News tomorrow? | moneymachine2 | |
01/3/2021 16:13 | Closing the day strongly - now up 4.5p at 87p-88p..... | rivaldo | |
01/3/2021 13:30 | Order your test kit for home. | moneymachine2 | |
01/3/2021 13:30 | https://www.gov.uk/o | moneymachine2 | |
01/3/2021 09:35 | Green Richard is cute x 🥰 | rebel_with_a_cause | |
01/3/2021 09:35 | I love green Richard x | rebel_with_a_cause | |
01/3/2021 09:34 | Riz help me plz take my mrs and pay me money 😢 | rebel_with_a_cause | |
01/3/2021 08:14 | Something very wrong here. 32M tests going out from next week and no contract for ODX. Even worse - those 32M tests are coming from somewhere!!!! Someone is manufacturing them. 😢😢 Have we been duped??? | specialistlegionsupercharged | |
01/3/2021 07:57 | Anyone see the RNS this morning | letmepass | |
01/3/2021 07:56 | Interesting re a USA trademark approval..... "bluejug2001 @bluejug2001 #Odx Trademark agreed in USA @Abingdon_Health @OmegaDiagnostic @UK_RTC | rivaldo |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions